• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diffuse hyperpigmented plaques as cutaneous manifestation of multicentric Castleman disease and treatment with thalidomide: report of three cases.

作者信息

Zhao Xiaoqing, Shi Ruofei, Jin Xiaolong, Zheng Jie

机构信息

Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.

Department of Pathology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.

出版信息

J Am Acad Dermatol. 2011 Aug;65(2):430-432. doi: 10.1016/j.jaad.2010.01.012.

DOI:10.1016/j.jaad.2010.01.012
PMID:21763571
Abstract
摘要

相似文献

1
Diffuse hyperpigmented plaques as cutaneous manifestation of multicentric Castleman disease and treatment with thalidomide: report of three cases.弥漫性色素沉着斑作为多中心Castleman病的皮肤表现及沙利度胺治疗：三例报告
J Am Acad Dermatol. 2011 Aug;65(2):430-432. doi: 10.1016/j.jaad.2010.01.012.
2
POEMS syndrome: are current diagnostic criteria too exclusive?POEMS综合征：当前的诊断标准是否过于严格？
J Am Acad Dermatol. 2011 Aug;65(2):415-417. doi: 10.1016/j.jaad.2010.06.046. Epub 2011 Apr 17.
3
Late-onset skin involvement on the forehead in multicentric Castleman disease.多中心性Castleman病患者前额出现迟发性皮肤受累。
Int J Dermatol. 2017 Jul;56(7):e152-e153. doi: 10.1111/ijd.13559. Epub 2017 Feb 27.
4
Castleman disease in differential diagnosis of a pancreatic mass.Castleman病在胰腺肿块鉴别诊断中的应用
Eur J Surg. 2002;168(12):744-6. doi: 10.1080/00000000000000015.
5
Multifocal Castleman disease in pediatrics: case report.小儿多灶性Castleman病：病例报告
J Pediatr Hematol Oncol. 2005 Dec;27(12):666-9. doi: 10.1097/01.mph.0000193468.06938.93.
6
Cutaneous involvement as initial presentation of multicentric plasmacytic Castleman disease.皮肤受累为多发性中心性Castleman 病的首发表现。
J Cutan Pathol. 2021 May;48(5):701-705. doi: 10.1111/cup.13964. Epub 2021 Mar 7.
7
Multicentric Castleman's disease manifesting in the lung: clinical, radiographic, and pathologic findings and successful treatment with corticosteroid and cyclophosphamide.肺部表现的多中心性Castleman病：临床、影像学和病理学表现及皮质类固醇和环磷酰胺治疗成功病例
Intern Med. 2003 Feb;42(2):182-6. doi: 10.2169/internalmedicine.42.182.
8
Multicentric Castleman's disease in two cases.两例多中心性Castleman病
Indian J Pediatr. 2007 Dec;74(12):1116-20. doi: 10.1007/s12098-007-0210-z.
9
The clinical behavior of localized and multicentric Castleman disease.局限性和多中心性Castleman病的临床行为
Ann Intern Med. 1998 Apr 15;128(8):657-62. doi: 10.7326/0003-4819-128-8-199804150-00010.
10
Flexural Hyperpigmentation With Reticulation in an Adolescent Girl.一名青春期女孩出现伴有网状结构的弯曲性色素沉着。
JAMA Dermatol. 2019 Mar 1;155(3):377-378. doi: 10.1001/jamadermatol.2018.5033.

引用本文的文献

1
Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report.托珠单抗治疗伴有肺部和皮肤病变的特发性多中心Castleman病：一例报告
World J Clin Cases. 2020 Oct 26;8(20):4922-4929. doi: 10.12998/wjcc.v8.i20.4922.
2
Afebrile Pneumonia in a Patient With Multicentric Castleman Disease on Siltuximab: Infection Without Fever on Anti-Interleukin-6 Therapy.接受司妥昔单抗治疗的多中心Castleman病患者的无热肺炎：抗白细胞介素-6治疗期间无发热的感染
Cureus. 2020 Jul 2;12(7):e8967. doi: 10.7759/cureus.8967.
3
Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases.
硼替佐米联合来那度胺挽救治疗复发/难治性Castleman 病三例报告
Front Med. 2017 Jun;11(2):287-292. doi: 10.1007/s11684-017-0510-2. Epub 2017 Apr 3.
4
Thalidomide for tocilizumab-resistant ascites with TAFRO syndrome.沙利度胺用于治疗托珠单抗耐药性腹水伴TAFRO综合征。
Clin Case Rep. 2015 Jun;3(6):472-8. doi: 10.1002/ccr3.284. Epub 2015 Apr 22.
5
Co-Existence of Multicentric Castleman's Disease and Kaposi's Sarcoma.多中心性Castleman病与卡波西肉瘤并存
Indian J Dermatol. 2015 May-Jun;60(3):323. doi: 10.4103/0019-5154.156457.